The portal for rare diseases and orphan drugs

Singh, Jatinder

WebwiseArchivesVol. 4 | Issue 2 | 2013 | pp. 168–9Open Access

The portal for rare diseases and orphan drugs

¹^*

¹Department of Pharmacology, Government Medical College, Amritsar, India.

Correspondence: Jatinder Singh
Department of Pharmacology, Government Medical College, Amritsar, India.
Email: singh@gmc.edu.in

Published: Jan 1, 2013

DOI: Not available yet
Article URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-4-2-168
PDF URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-4-2-168.pdf

Abstract

Orphan drugs are the stepchildren of the pharmaceutical industry. These medicinal products that are used primarily for the prevention or treatment of life‑threatening or debilitating rare diseases have restricted markets and thus limited profitability. As a consequence, the pharmaceutical industry has little interest in developing and marketing these drugs which are intended for patients who suffer from rare conditions.

Keywords

Subject

Readers Also Viewed

Original Research Article

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Annisa Fatharani, Ali Alsayegh

Jan 1, 2026

Review Article

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Mohammad Akbar Hossain

Jan 1, 2026

Original Research Article

Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia

Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby

Jan 1, 2026

Abstract

Keywords

Subject

Recommended articles

Readers Also Viewed

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia